Stay updated with breaking news from Assal Hellmer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
As the first-ever U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) naloxone in 2023, Emergent is working to expand access with NARCAN® Nasal Spray and build on its longstanding
Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company’s debt GAITHERSBURG, Md., Feb. 21, 2024 -- Emergent BioSolutions...
GAITHERSBURG, Md., Jan. 09, 2024 -- Emergent BioSolutions , a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today...
GAITHERSBURG, Md., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS), a global company providing solutions that address public health threats and brings lifesaving, life-extending products to market, today
Emergent BioSolutions Receives NYSE Notice Regarding Delayed Form 10-Q Filing GAITHERSBURG, Md., November 24, 2023 - Emergent BioSolutions Inc. today confirmed...